Treffer 1 - 2 von 2 für Suche 'Basiricò, Marco', Suchdauer: 0,38s Treffer weiter einschränken
  1. 1
    CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

    CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma von Giraudo, Lidia, Cattaneo, Giulia, Gammaitoni, Loretta, Iaia, Ilenia, Donini, Chiara, Massa, Annamaria, Centomo, Maria Laura, Basiricò, Marco, Vigna, Elisa, Pisacane, Alberto, Picciotto, Franco, Berrino, Enrico, Marchiò, Caterina, Merlini, Alessandra, Paruzzo, Luca, Poletto, Stefano, Caravelli, Daniela, Biolato, Andrea Michela, Bortolot, Valentina, Landoni, Elisa, Ventin, Marco, Ferrone, Cristina R, Aglietta, Massimo, Dotti, Gianpietro, Leuci, Valeria, Carnevale-Schianca, Fabrizio, Sangiolo, Dario


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

    The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma von Pignochino, Ymera, Dell'Aglio, Carmine, Inghilleri, Simona, Zorzetto, Michele, Basiricò, Marco, Capozzi, Federica, Canta, Marta, Piloni, Davide, Cemmi, Francesca, Sangiolo, Dario, Gammaitoni, Loretta, Soster, Marco, Marchiò, Serena, Pozzi, Ernesto, Morbini, Patrizia, Luisetti, Maurizio, Aglietta, Massimo, Grignani, Giovanni, Stella, Giulia M

    Veröffentlicht in BMC cancer

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: